glucuronic acid has been researched along with c-peptide in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alpsten, M; Holm, G; Sandberg, AS; Tölli, J; Torsdottir, I | 1 |
| Duvivier-Kali, VF; O'Neil, JJ; Omer, A; Parent, RJ; Weir, GC | 1 |
| Foster, JL; Keogh, GW; Philips, R; Tuch, BE; Vaithilingam, V; Williams, LJ; Wu, W | 1 |
| Dufrane, D; Gianello, P; Goebbels, RM | 1 |
| Chintinne, M; Delvaux, G; Gillard, P; Gorus, F; Jacobs-Tulleneers-Thevissen, D; Keymeulen, B; Ling, Z; Pipeleers, D; Schoonjans, L; Strand, BL | 1 |
2 trial(s) available for glucuronic acid and c-peptide
| Article | Year |
|---|---|
A small dose of soluble alginate-fiber affects postprandial glycemia and gastric emptying in humans with diabetes.
Topics: Adult; Alginates; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet, Reducing; Dietary Fiber; Gastric Emptying; Glucuronic Acid; Hexuronic Acids; Humans; Insulin; Male; Middle Aged; Solubility | 1991 |
Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient.
Topics: Alginates; Animals; Blood Glucose; C-Peptide; Cells, Cultured; Diabetes Mellitus, Type 1; Female; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Middle Aged; Peritoneal Cavity | 2013 |
3 other study(ies) available for glucuronic acid and c-peptide
| Article | Year |
|---|---|
Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane.
Topics: Alginates; Animals; Autoimmunity; Biocompatible Materials; Blood Glucose; C-Peptide; Capsules; Coculture Techniques; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucose Tolerance Test; Glucuronic Acid; Graft Rejection; Graft Survival; Hexuronic Acids; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Inbred Strains; Spleen; Subrenal Capsule Assay; T-Lymphocytes; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic | 2001 |
Safety and viability of microencapsulated human islets transplanted into diabetic humans.
Topics: Adult; Alginates; Blood Glucose; C-Peptide; Capsules; Cell Survival; Diabetes Mellitus, Type 1; Female; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans Transplantation; Male; Middle Aged | 2009 |
Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression.
Topics: Alginates; Animals; Antibodies, Heterophile; Blood Glucose; C-Peptide; Capsules; Diabetes Mellitus, Experimental; Glucuronic Acid; Glycated Hemoglobin; Graft Survival; Hexuronic Acids; Immunosuppression Therapy; Insulin; Islets of Langerhans Transplantation; Macaca fascicularis; Subcutaneous Tissue; Sus scrofa; Time Factors; Transplantation, Heterologous | 2010 |